Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by ProfCorneliuson Mar 20, 2020 5:38pm
608 Views
Post# 30832133

Aphria Diamond is in full rotation and

Aphria Diamond is in full rotation and that together with Aphria One is still not enough to meet the INSATIABLE demand for Aphria's dried flower and REC 2.0 products. Q4 2020 is going to be the moment that Aphria ascends to the top of the LP mountain permanently. If this demand scenario sustains itself I'm calling for a Q4 2020 where by Aphria's cannabis revenues will equal that of CC Pharmas for the Q. Ya that's right!!! 90 plus mill $$$$$ . PROF
<< Previous
Bullboard Posts
Next >>